OncoCyte Corporation (OCX)
NASDAQ: OCX · IEX Real-Time Price · USD
2.930
-0.010 (-0.34%)
Mar 28, 2024, 3:59 PM EDT - Market closed

OncoCyte Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013
Revenue
0.962.21.220000000
Revenue Growth (YoY)
-56.41%80.76%--------
Cost of Revenue
0.980.781.860000000
Gross Profit
-0.021.42-0.640000000
Selling, General & Admin
23.0122.8423.2815.458.6911.685.464.191.010.55
Research & Development
7.35.049.86.796.517.175.684.533.962.94
Other Operating Expenses
-12.3427.27-4.010000000
Operating Expenses
17.9855.1529.0722.2415.218.8511.148.724.973.5
Operating Income
-18-53.73-29.71-22.24-15.2-18.85-11.14-8.72-4.97-3.5
Interest Expense / Income
0.080.210.250.3-0.220.220.030.0200
Other Expense / Income
54.8319.421.22-0.110.770.31--00.01-
Pretax Income
-72.9-73.36-31.19-22.43-15.75-19.38-11.17-8.74-4.99-3.5
Income Tax
0-9.26-1.250000000
Net Income
-72.9-64.1-29.93-22.43-15.75-19.38-11.17-8.74-4.99-3.5
Preferred Dividends
0.52000000000
Net Income Common
-73.42-64.1-29.93-22.43-15.75-19.38-11.17-8.74-4.99-3.5
Shares Outstanding (Basic)
6433221111
Shares Outstanding (Diluted)
6433221111
Shares Change
24.61%35.80%27.65%35.52%25.35%13.82%26.27%15.43%--
EPS (Basic)
-13.20-14.40-9.20-8.80-8.40-12.80-8.40-8.40-5.40-3.80
EPS (Diluted)
-13.20-14.40-9.20-8.80-8.40-12.80-8.40-8.40-5.40-3.80
Free Cash Flow
-49.91-38.19-27.21-20.63-11.68-13.48-7.63-4.73-1.17-0.74
Free Cash Flow Per Share
-9.01-8.59-8.31-8.04-6.17-8.93-5.75-4.50-1.29-0.81
Gross Margin
-1.88%64.60%-52.55%-------
Operating Margin
-1878.60%-2444.27%-2443.34%-------
Profit Margin
-7664.09%-2916.15%-2461.51%-------
Free Cash Flow Margin
-5209.60%-1737.40%-2237.42%-------
EBITDA
-67.61-68.94-30.54-21.78-15.41-18.58-10.75-8.43-4.7-3.22
EBITDA Margin
-7056.89%-3136.67%-2511.51%-------
Depreciation & Amortization
5.224.210.390.350.560.580.390.280.280.28
EBIT
-72.83-73.15-30.93-22.13-15.97-19.16-11.14-8.72-4.98-3.5
EBIT Margin
-7601.77%-3327.98%-2543.91%-------
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).